Inventor · disambiguated record
Atsushi Kumanogoh
Also filed as: KUMANOGOH ATSUSHI
7 granted patents·16 pending applications·17 citations·filing 2003–2024
80Inventor score
Top patents by PatentIndex Score
23 records- 0196US10988540B2AntibodyUNIV OSAKA·Filed 2020·Granted Apr 27, 2021·4 cites·12 claims
- 0291US10654931B2AntibodyUNIV OSAKA·Filed 2016·Granted May 19, 2020·5 cites·8 claims
- 0387US2024360222A1AntibodyUNIV OSAKA·Filed 2024·Application pending·0 cites
- 0485US10688178B2AntiPlexin A1 agonist antibodyUNIV OSAKA·Filed 2016·Granted Jun 23, 2020·4 cites·22 claims
- 0577US7462461B2Compositions for inhibiting Sema7A and VLA-1 interaction and the methods of using the sameBOEHRINGER INGELHEIM INT·Filed 2006·Granted Dec 9, 2008·4 cites·3 claims
- 0677US2023357390A1ANTI-CD98hc ANTIBODYUNIV OSAKA·Filed 2023·Application pending·0 cites
- 0775US2022041735A1AntibodyUNIV OSAKA·Filed 2021·Application pending·0 cites
- 0871US2020283533A1AntibodyUNIV OSAKA·Filed 2020·Application pending·0 cites
- 0969US12474337B2Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agentUNIV OSAKA·Filed 2020·Granted Nov 18, 2025·0 cites·4 claims
- 1069US2022064287A1ANTI-CD98hc ANTIBODYUNIV OSAKA·Filed 2021·Application pending·0 cites
- 1163US11576969B2AntiPlexin A1 agonist antibodyUNIV OSAKA·Filed 2020·Granted Feb 14, 2023·0 cites·13 claims
- 1262US10794907B2Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agentUNIV OSAKA·Filed 2014·Granted Oct 6, 2020·0 cites·9 claims
- 1356US2008058257A1Costimulatory Molecules and Uses thereofKIKUTANI HITOSHI·Filed 2007·Application pending·0 cites
- 1456US2008317766A1Costimulatory Molecules and Uses ThereofKIKUTANI HITOSHI·Filed 2008·Application pending·0 cites
- 1555US2007237773A1Human sema4a protein antibodies and uses thereofKIKUTANI HITOSHI·Filed 2007·Application pending·0 cites
- 1654US2018230212A1AntibodyUNIV OSAKA·Filed 2016·Application pending·0 cites
- 1752US2007160604A1Methods of identifying compounds capable of modulating t cell immune responses involving sema4a proteinKIKUTANI HITOSHI·Filed 2007·Application pending·0 cites
- 1849US2004052782A1Costimulatory molecules and uses thereofBOEHRINGER INGELHEIM INT·Filed 2003·Application pending·0 cites
- 1945US2012322085A1Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agentKUMANOGOH ATSUSHI·Filed 2010·Application pending·0 cites
- 2044US2021113594A1Tumor immunomodulatorUNIV OSAKA·Filed 2019·Application pending·0 cites
- 2140US2020270686A1Eye disease biomarkerUNIV OSAKA·Filed 2017·Application pending·0 cites
- 2238US2019119747A1Stress biomarkerUNIV OSAKA·Filed 2017·Application pending·0 cites
- 2337US2008045443A1Compositions for Inhibiting plexin-A1-DAP12 interactions and Methods of Treating Inflammatory, Autoimmune or Bone Resorption Diseases Using the SameKIKUTANI HITOSHI·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Atsushi Kumanogoh files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →